A Cell-Based Assay for RNA Synthesis by the HCV Polymerase
Author Information
Author(s): Ranjith-Kumar C. T., Wen Yahong, Baxter Nielson Bhardwaj, Kanchan Cheng Kao C.
Primary Institution: Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, Indiana, United States of America
Hypothesis
Can the HCV polymerase activity be effectively analyzed using a cell-based assay?
Conclusion
The 5BR assay can be used to validate inhibitors of the HCV polymerase and elucidate requirements for HCV-dependent RNA synthesis.
Supporting Evidence
- The 5BR assay can validate inhibitors of the HCV polymerase.
- Mutations in the HCV polymerase that affect RNA synthesis also impact RIG-I signaling.
- NS5A inhibits the activity of the HCV polymerase in a concentration-dependent manner.
- All six major HCV genotypes showed robust activation of RIG-I in the 5BR assay.
Takeaway
Researchers created a test to see how a virus makes its RNA, which helps in finding new medicines to fight it.
Methodology
The study used HEK 293T cells to develop a cell-based assay that measures RNA synthesis by the HCV polymerase and its interaction with innate immune receptors.
Limitations
The assay may not fully replicate the complex interactions occurring in a natural infection environment.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website